Search Results - Maoz‐Segal, R.

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency

    Immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency by Shavit, R., Maoz‐Segal, R., Prizinsky, S., Haj‐Yahia, S., Offengenden, I., Machnas‐Mayan, D., Tunisky, Y., Iancovici‐Kidon, M., Agmon‐Levin, N.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Hydroxychloroquine desensitization, an effective method to overcome hypersensitivity—a multicenter experience

    Hydroxychloroquine desensitization, an effective method to overcome hypersensitivity—a multicenter experience by Tal, Y, Maoz Segal, R, Langevitz, P, Kivity, S, Darnizki, Z, Agmon-Levin, N

    Published in Lupus
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency

    Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency by Shavit, R, Maoz-Segal, R, Frizinsky, S, Haj-Yahia, S, Offengenden, I, Machnas-Mayan, D, Tunisky, Y, Iancovici-Kidon, M, Agmon-Levin, N

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    PO.8.168 The third dose of mRNA COVID 19 vaccine is safe and efficacious for SLE patients receiving belimumab

    PO.8.168 The third dose of mRNA COVID 19 vaccine is safe and efficacious for SLE patients receiving belimumab by Tunitsky-Lifshitz, Y, Maoz-Segal, R, Iancovici-Kidon, M, Niznik, S, Shavit, R, Haj Yahia, S, Agmon-Levin, N

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: